1. Kouchaki, Ebrahim, Nikoueinejad, Hassan, Akbari, Hossein, Azimi, Shirin, Behnam, Mohammad. 2019. The investigation of relevancy between PIAS1 and PIAS2 gene expression and disease severity of multiple sclerosis. In Journal of immunoassay & immunochemistry, 40, 396-406. doi:10.1080/15321819.2019.1613244. https://pubmed.ncbi.nlm.nih.gov/31084243/
2. Li, Yuanqing, Lin, Hongchun, Shu, Shuangshuang, Hu, Zhaoyong, Peng, Hui. . Integrative transcriptome analysis reveals TEKT2 and PIAS2 involvement in diabetic nephropathy. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36, e22592. doi:10.1096/fj.202200740RR. https://pubmed.ncbi.nlm.nih.gov/36251411/
3. Pan, Yongjie, Dai, Jinhua, Liao, Yufeng, Yu, Qiuyun. . MicroRNA-137 promotes hepatitis B virus gene expression and replication via targeting the protein inhibitor of activated STAT 2. In Die Pharmazie, 72, 550-554. doi:10.1691/ph.2017.7594. https://pubmed.ncbi.nlm.nih.gov/29441983/
4. Shu, Hang, Chen, Xiaoyu, Zhao, Jie, Li, Ping, Sun, Zhen. 2024. PIAS family gene expression: implications for prognosis, immunomodulation, and chemotherapy response. In American journal of translational research, 16, 6346-6364. doi:10.62347/JRDP4018. https://pubmed.ncbi.nlm.nih.gov/39678595/
5. Guo, Jing, Chen, Dan, Gao, Xiaoxiao, Pei, Rongjuan, Chen, Xinwen. 2017. Protein Inhibitor of Activated STAT2 Restricts HCV Replication by Modulating Viral Proteins Degradation. In Viruses, 9, . doi:10.3390/v9100285. https://pubmed.ncbi.nlm.nih.gov/28973998/